Table 2. sUA, SCr, cys-c, eGFR levels before and after treatment (means±SD).

Group	n	time	sUA (µmol/L)	SCr (µmol/L)	cys-c (mg/L)	eGFR (mL/min)
Treatment group	18
before treatment			447.5±83.6	172.9±20.1	1.98 ±0.21	45.3±10.6
treatment for four weeks			370.5±72.1* ▲	141.1±24.9* ▲	1.35 ±0.16* ▲	52.8±11.5* ▲
eight weeks			334.1±49.8* ▲	139.8±35.1* ▲	1.28 ±0.13* ▲	50.9±13.7* ▲
twelve weeks			297.4±51.1* ▲	132.9±27.8* ▲	1.30 ±0.22* ▲	53.1±10.2* ▲
twenty-four weeks			301.2±46.9* ▲	148.1±30.2* ▲	1.33±0.33* ▲	53.8±9.6* ▲
non-treatment group	20
before treatment			423.4±51.2	157.7±38.3	1.55±0.291	46.8±9.0
treatment for four weeks			419.1±60.1	163.2±35.9	1.48±0.40	48.2±10.4
eight weeks			427.8±46.8	153.3±29.8	1.53±0.33	45.6±11.7
twelve weeks			397.4±74.2	169.9±40.3	1.61±0.29	47.2±9.8
twenty-four weeks			421.1±55.7	170.6±51.9	1.70±0.52	42.7±13.4

^*Significant difference between the treatment group and the non-treatment group (P<0.05);

^▲significant differences before and after treatment in the treatment group (P<0.05).